How Biotech Firms Kept Raw Material Shortages From Affecting Patients During Pandemic

Biogen, Amgen, Lilly and Genentech experts shared tales of impending stockouts, particularly for single-use assemblies, filters and resins, and some of the measures they took to prevent them from causing drug shortages.